Keith Killian

1.4k total citations
24 papers, 448 citations indexed

About

Keith Killian is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Keith Killian has authored 24 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Keith Killian's work include Cancer Genomics and Diagnostics (6 papers), Neuroblastoma Research and Treatments (4 papers) and Lung Cancer Research Studies (3 papers). Keith Killian is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Neuroblastoma Research and Treatments (4 papers) and Lung Cancer Research Studies (3 papers). Keith Killian collaborates with scholars based in United States, Italy and France. Keith Killian's co-authors include Paul S. Meltzer, Maria J. Merino, Martha Quezado, Miia Suuriniemi, Katherine E. Warren, Paul C. Herrmann, Emanuel F. Petricoin, Mauro Ferrari, David Geho and Mark Ming‐Cheng Cheng and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Oncogene.

In The Last Decade

Keith Killian

24 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Killian United States	10	203	125	117	65	59	24	448
Jun-ichiro Kuroda Japan	13	136 0.7×	133 1.1×	92 0.8×	52 0.8×	93 1.6×	25	497
Jun‐ichiro Kuroda Japan	14	272 1.3×	127 1.0×	58 0.5×	139 2.1×	116 2.0×	34	619
Harry R. Haynes United Kingdom	13	163 0.8×	101 0.8×	76 0.6×	161 2.5×	31 0.5×	32	455
Cristina Birzu France	7	88 0.4×	115 0.9×	122 1.0×	173 2.7×	30 0.5×	19	386
E. Benericetti Italy	10	102 0.5×	106 0.8×	65 0.6×	120 1.8×	117 2.0×	20	460
Jian Yi Li United States	13	248 1.2×	59 0.5×	99 0.8×	142 2.2×	11 0.2×	31	510
Mamta Wankhede United States	11	177 0.9×	54 0.4×	168 1.4×	205 3.2×	102 1.7×	15	689
Ya-Jui Lin Taiwan	11	91 0.4×	97 0.8×	54 0.5×	148 2.3×	224 3.8×	27	521
Aurélie Prignon France	15	249 1.2×	202 1.6×	69 0.6×	20 0.3×	47 0.8×	25	647
Yanming Qu China	13	156 0.8×	51 0.4×	63 0.5×	48 0.7×	67 1.1×	41	431

Countries citing papers authored by Keith Killian

Since Specialization

Citations

This map shows the geographic impact of Keith Killian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Killian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Killian more than expected).

Fields of papers citing papers by Keith Killian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Killian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Killian. The network helps show where Keith Killian may publish in the future.

Co-authorship network of co-authors of Keith Killian

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Killian. A scholar is included among the top collaborators of Keith Killian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Killian. Keith Killian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Qiuyi, Ying Gao, Lynn R. Goldin, et al.. (2023). Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia. Frontiers in Genetics. 13. 1056043–1056043. 3 indexed citations

Girard, Nicolas, Clémence Basse, Alexa B. Schrock, et al.. (2022). Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers. The Oncologist. 27(11). 919–929. 27 indexed citations

Necchi, Andrea, Petros Grivas, Gennady Bratslavsky, et al.. (2020). Comprehensive genomic profiling (CGP) in post-systemic treatment (Post) metastatic sites (MET) and pretreatment (Pre) primary tumors (PT) of metastatic prostate cancer (mPC).. Journal of Clinical Oncology. 38(6_suppl). 175–175. 1 indexed citations

Grivas, Petros, Andrea Necchi, Gennady Bratslavsky, et al.. (2020). The emerging target KRAS G12C in genitourinary malignancies.. Journal of Clinical Oncology. 38(6_suppl). 434–434. 1 indexed citations

Yakirevich, Evgeny, Carmen M. Perrino, Andrea Necchi, et al.. (2020). NF2 mutation-driven renal cell carcinomas (RCC): A comprehensive genomic profiling (CGP) study.. Journal of Clinical Oncology. 38(6_suppl). 726–726. 4 indexed citations

Ross, Jeffrey S., Ethan S. Sokol, Jo‐Anne Vergilio, et al.. (2020). Primary versus metastatic intrahepatic cholangiocarcinoma: A comparative comprehensive genomic profiling (CGP) study.. Journal of Clinical Oncology. 38(4_suppl). 578–578. 6 indexed citations

Ross, Jeffrey S., Ethan S. Sokol, Holger Moch, et al.. (2019). Comprehensive genomic profiling (CGP) of carcinoma of unknown primary origin (CUP): Retrospective molecular classification of potentially eligible patients (pts) for targeted or immunotherapy treatment (tx) using the prospective CUPISCO trial’s criteria. Annals of Oncology. 30. v934–v934. 4 indexed citations

Rivero, Jaydira Del, Fernanda I. Arnaldez, Ramaprasad Srinivasan, et al.. (2018). A phase II trial of the DNA methyl transferase inhibitor, SGI-110 (guadecitabine), in children and adults with wild type GIST, pheochromocytoma and paraganglioma associated with succinate dehydrogenase deficiency and HLRCC-associated kidney cancer.. Journal of Clinical Oncology. 36(15_suppl). TPS2608–TPS2608. 2 indexed citations

Karzai, Fatima, Ravi A. Madan, Helen Owens, et al.. (2018). A phase 2 study of olaparib and durvalumab in metastatic castrate-resistant prostate cancer (mCRPC) in an unselected population.. Journal of Clinical Oncology. 36(6_suppl). 163–163. 36 indexed citations

10.

Wu, Shengyang, Benjamin T. Cooper, Christopher Bowman, et al.. (2017). A DNA methylation-based classifier for accurate molecular diagnosis of bone sarcomas.. Journal of Clinical Oncology. 35(15_suppl). 11034–11034. 2 indexed citations

11.

Patel, Dhaval, Astin S. Powers, Martha Quezado, et al.. (2017). Somatic VHL Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case Report. Journal of the Endocrine Society. 1(9). 1124–1134. 5 indexed citations

12.

Kothari, Shalin, Daniel L. Gustafson, Keith Killian, et al.. (2016). COXEN prediction of antineoplastic drug sensitivity in bladder cancer patients.. Journal of Clinical Oncology. 34(2_suppl). 365–365. 2 indexed citations

13.

Kothari, Shalin, Daniel L. Gustafson, Keith Killian, et al.. (2015). COXEN prediction of antineoplastic drug sensitivity in bladder cancer patients.. Journal of Clinical Oncology. 33(15_suppl). e15533–e15533. 1 indexed citations

14.

Lau, Christopher, Keith Killian, Yardena Samuels, & Udo Rudloff. (2013). ERBB4 Mutation Analysis: Emerging Molecular Target for Melanoma Treatment. Methods in molecular biology. 1102. 461–480. 21 indexed citations

15.

Giaccone, Giuseppe, Ariel López-Chávez, Anish Thomas, et al.. (2013). Custom (Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies) trial.. Journal of Clinical Oncology. 31(15_suppl). 7513–7513. 5 indexed citations

16.

Aung, Phyu P., et al.. (2012). Primary neuroendocrine tumors of the kidney: morphological and molecular alterations of an uncommon malignancy. Human Pathology. 44(5). 873–880. 27 indexed citations

17.

Petrini, Iacopo, Paul S. Meltzer, Paolo Andrea Zucali, et al.. (2012). Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors. Cell Death and Disease. 3(7). e351–e351. 79 indexed citations

18.

Lake, Robert J., Pauline L. Martin, Keith Killian, et al.. (2012). CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model. Oncogene. 32(22). 2726–2738. 58 indexed citations

19.

Warren, Katherine E., et al.. (2011). Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro-Oncology. 14(3). 326–332. 56 indexed citations

20.

Nijdam, A.J., Mark Ming‐Cheng Cheng, David Geho, et al.. (2006). Physicochemically modified silicon as a substrate for protein microarrays. Biomaterials. 28(3). 550–558. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact